Annovis Bio, Inc. (ANVS) Total liabilities 2019–2025
Annovis Bio, Inc. (ANVS) total liabilities at each fiscal year-end, per SEC filings.
$4.2MFY2025 · since FY2019: $2.6M → $4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.2M | -8.4% |
| FY2024 | $4.6M | -74.3% |
| FY2023 | $18.0M | +133.3% |
| FY2022 | $7.7M | +411.0% |
| FY2021 | $1.5M | +160.5% |
| FY2020 | $578,380 | -77.9% |
| FY2019 | $2.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANVS financial trends
ANVS RevenueANVS Net incomeANVS Net marginANVS Gross profitANVS Gross marginANVS Operating incomeANVS Operating marginANVS Operating cash flowANVS Free cash flowANVS Capital expendituresANVS Return on equityANVS Stock buybacksANVS Dividends paidANVS Total assetsANVS Shareholders’ equityANVS overview →